Sengeløv L - Search Results

1

The immunogenicity of the hTERT540-548 peptide in cancer.

Wenandy L, Sørensen RB, Sengeløv L, Svane IM, thor Straten P, Andersen MH. Wenandy L, et al. Among authors: sengelov l. Clin Cancer Res. 2008 Jan 1;14(1):4-7. doi: 10.1158/1078-0432.CCR-07-4590. Clin Cancer Res. 2008. PMID: 18172245 Review.

2

Clinical Impact of the Number of Treatment Cycles in First-Line Docetaxel for Patients With Metastatic Castration-Resistant Prostate Cancer.

Kongsted P, Svane IM, Lindberg H, Sengeløv L. Kongsted P, et al. Among authors: sengelov l. Clin Genitourin Cancer. 2017 Apr;15(2):e281-e287. doi: 10.1016/j.clgc.2016.08.019. Epub 2016 Sep 8. Clin Genitourin Cancer. 2017. PMID: 27692811

3

Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study.

Kongsted P, Borch TH, Ellebaek E, Iversen TZ, Andersen R, Met Ö, Hansen M, Lindberg H, Sengeløv L, Svane IM. Kongsted P, et al. Among authors: sengelov l. Cytotherapy. 2017 Apr;19(4):500-513. doi: 10.1016/j.jcyt.2017.01.007. Epub 2017 Feb 15. Cytotherapy. 2017. PMID: 28215654 Clinical Trial.

4

Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer.

Idorn M, Køllgaard T, Kongsted P, Sengeløv L, Thor Straten P. Idorn M, et al. Among authors: sengelov l. Cancer Immunol Immunother. 2014 Nov;63(11):1177-87. doi: 10.1007/s00262-014-1591-2. Epub 2014 Aug 2. Cancer Immunol Immunother. 2014. PMID: 25085000 Free PMC article.

5

Low-dose prednisolone in first-line docetaxel for patients with metastatic castration-resistant prostate cancer: is there a clinical benefit?

Kongsted P, Svane IM, Lindberg H, Daugaard G, Sengeløv L. Kongsted P, et al. Among authors: sengelov l. Urol Oncol. 2015 Nov;33(11):494.e15-20. doi: 10.1016/j.urolonc.2015.06.022. Epub 2015 Aug 5. Urol Oncol. 2015. PMID: 26254696

6

Predictors of Chemotherapy-Induced Toxicity and Treatment Outcomes in Elderly Versus Younger Patients With Metastatic Castration-Resistant Prostate Cancer.

Kongsted P, Svane IM, Lindberg H, Sengeløv L. Kongsted P, et al. Among authors: sengelov l. Clin Genitourin Cancer. 2016 Dec;14(6):e559-e568. doi: 10.1016/j.clgc.2016.03.018. Epub 2016 Mar 24. Clin Genitourin Cancer. 2016. PMID: 27102406

7

Cabazitaxel as second-line or third-line therapy in patients with metastatic castration-resistant prostate cancer.

Kongsted P, Svane IM, Lindberg H, Bisbjerg R, Daugaard G, Sengeløv L. Kongsted P, et al. Among authors: sengelov l. Anticancer Drugs. 2016 Aug;27(7):695-701. doi: 10.1097/CAD.0000000000000375. Anticancer Drugs. 2016. PMID: 27148775

8

Emmprin and survivin predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer.

Als AB, Dyrskjøt L, von der Maase H, Koed K, Mansilla F, Toldbod HE, Jensen JL, Ulhøi BP, Sengeløv L, Jensen KM, Orntoft TF. Als AB, et al. Among authors: sengelov l. Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4407-14. doi: 10.1158/1078-0432.CCR-07-0109. Clin Cancer Res. 2007. PMID: 17671123

9

Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer.

Beer TM, Kwon ED, Drake CG, Fizazi K, Logothetis C, Gravis G, Ganju V, Polikoff J, Saad F, Humanski P, Piulats JM, Gonzalez Mella P, Ng SS, Jaeger D, Parnis FX, Franke FA, Puente J, Carvajal R, Sengeløv L, McHenry MB, Varma A, van den Eertwegh AJ, Gerritsen W. Beer TM, et al. Among authors: sengelov l. J Clin Oncol. 2017 Jan;35(1):40-47. doi: 10.1200/JCO.2016.69.1584. Epub 2016 Oct 31. J Clin Oncol. 2017. PMID: 28034081 Clinical Trial.

10

p53 nuclear immunoreactivity as a predictor of response and outcome following chemotherapy for metastatic bladder cancer.

Sengeløv L, Horn T, Steven K. Sengeløv L, et al. J Cancer Res Clin Oncol. 1997;123(10):565-70. doi: 10.1007/s004320050106. J Cancer Res Clin Oncol. 1997. PMID: 9393591

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page